Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 186 (1) , 20-28
- https://doi.org/10.1016/j.atherosclerosis.2005.06.046
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pathophysiology of Vascular Calcification in Chronic Kidney DiseaseCirculation Research, 2004
- Vitamin D analogs: Actions and role in the treatment of secondary hyperparathyroidismSeminars in Nephrology, 2004
- Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause MortalityJournal of the American Society of Nephrology, 2004
- Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis populationNephrology Dialysis Transplantation, 2004
- Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol TherapyNew England Journal of Medicine, 2003
- Do associations with C-Reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?Journal of the American College of Cardiology, 2003
- Why is coronary heart disease of uraemic patients so frequent and so devastating?Nephrology Dialysis Transplantation, 2003
- Vitamin D analogues for secondary hyperparathyroidismNephrology Dialysis Transplantation, 2002
- Central role of VDR conformations for understanding selective actions of vitamin D3 analoguesSteroids, 2001
- Morphology of coronary atherosclerotic lesions in patients with end-stage renal failureNephrology Dialysis Transplantation, 2000